Programs will leverage ABL Bio's Grabody-B platform technology to deliver molecules across the blood-brain barrier.

The pharmaceutical manufacturing sector in Japan is poised for significant growth, with the market expected to surge from a valuation of US$ 34.7 billion in 2024 to a projected US ...

With a market projected to reach US$ 2,301.6 billion by 2032, the pharmaceutical manufacturing industry is not just growing—it’s evolving. The convergence of digital innovation, changing disease ...

The pharma giant is wagering potentially billions of dollars on technology from ABL Bio that’s designed to get drugs across ...

GSK is paying to access ABL Bio’s Grabody-B platform, which potentially enables therapies to cross the blood-brain barrier.

GSK has continued to flesh out its neuroscience strategy with a 2 billion pound sterling ($2.5 billion) deal to use a South ...

I am Genotype AS and have not been in any hospital for 30 years, or for as long as I can remember, to be treated for malaria fever. I am bitten my mosquitoes every day. If you put my resilience to not ...

Explore how U.S. tariffs and vaccine skepticism may impact GSK plc's profitability. Click for my update as tariffs are ...

With this in mind, we will now have a look at the 8 Most Undervalued Healthcare Stocks To Buy According To Analysts. For our ...

For GSK’s Ramakrishnan, who has served as CDTO since 2021, the biggest challenge was helping her company get a head start in this revolution. Ramakrishnan has been named to the ...

GSK Plc is studying a large group of elderly adults in the UK to determine if its blockbuster shingles vaccine reduces the risk of dementia, potentially opening the door to an expanded label for the ...

LONDON, March 25 (Reuters) - GSK (GSK.L), opens new tab said on ... Maggie is a Britain-based reporter covering the European pharmaceuticals industry with a global perspective.